We’ve made it easy to incorporate into any clinical microbiology workflow.
Screen for colonization to quickly determine facility/Healthcare System’s MDRO rates. Knowledge of a patient’s MDROs status entering the institution may protect patients and aid in antibiotic stewardship programs.
For symptomatic patients, send isolates either daily or weekly to see emerging resistance trends.
Swabs: Identify 10 genes associated with CRE, Carbapenemase producers, CTX-M related ESBLs and VRE.
Full work-up of specimen allows for rapid screening and surveillance of infection control risks.
Isolates: Genetic characterization of isolates analyzing 46 resistance genes and over 900 subtypes. Type, track, and compare MDROs infected patients throughout institutions using the Acuitas Lighthouse® Profile.
A comprehensive patient protection program that requires no significant labor, capital investment, validations or specialized skill sets.